Back to search
Bronchiolitis Obliterans Syndrome (BOS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bronchiolitis Obliterans Syndrome (BOS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Bronchiolitis Obliterans Syndrome (BOS) trials you may qualify forThe goal of this clinical trial is to learn about the safety and effectiveness of LAM-001 in patients who have developed bronchiolitis obliterans syndrome (BOS)…
This observational trial studies whether respiratory viruses are the cause of lung disease (bronchiolitis obliterans syndrome \[BOS\] or graft-versus-host disea…
This study investigates the safety and tolerability of Nintedanib in patients with bronchiolitis obliterans syndrome (BOS) following allogeneic hematopoietic ce…
The goal of this Phase 3 clinical trial is to compare ARINA-1 (a nebulized immunomodulatory agent) plus Standard of Care vs Standard of Care alone. The main que…
The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and doubl…
The primary aims of this study is to determine the efficacy and tolerability of Extracorporeal Photopheresis (ECP) for the treatment of either Refractory Bronch…